Capital Impact Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-23,228
Closed -$351K 95
2024
Q1
$351K Sell
23,228
-40,363
-63% -$732K 0.46% 81
2023
Q4
$1.37M Buy
63,591
+50,710
+394% +$936K 1.8% 9
2023
Q3
$239K Hold
12,881
0.4% 93
2023
Q2
$326K Buy
12,881
+969
+8% +$24.4K 0.36% 126
2023
Q1
$309K Buy
11,912
+1,973
+20% +$52.8K 0.38% 124
2022
Q4
$235K Buy
9,939
+755
+8% +$20.4K 0.23% 175
2022
Q3
$246K Buy
9,184
+307
+3% +$10.8K 0.25% 161
2022
Q2
$295K Sell
8,877
-2,703
-23% -$115K 0.27% 162
2022
Q1
$835K Buy
+11,580
New +$834K 0.61% 64
2021
Q4
Sell
-13,258
Closed -$1.68M 142
2021
Q3
$1.68M Sell
13,258
-14,897
-53% -$2.17M 0.67% 64
2021
Q2
$4.68M Buy
28,155
+15,780
+128% +$2.56M 1.51% 11
2021
Q1
$2.25M Sell
12,375
-21,821
-64% -$5.06M 0.79% 54
2020
Q4
$6.84M Buy
34,196
+21,696
+174% +$4.41M 1.68% 13
2020
Q3
$2.74M Buy
12,500
+5,500
+79% +$1.16M 0.81% 55
2020
Q2
$1.34M Buy
+7,000
New +$1.23M 0.45% 97

Other funds holding TDOC

Capital Impact Advisors's TDOC Position: Q2 2024 in Review

Capital Impact Advisors sold out of Teladoc Health (TDOC) in Q2 2024, closing a stake of 23,228 shares — an estimated $351K sold.

Capital Impact Advisors first reported a position in TDOC in Q2 2020 and held it in 15 quarters. The position peaked at $6.84M in Q4 2020. 405 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

  • Capital Impact Advisors reported no remaining Teladoc Health position as of Q2 2024 after selling out during the quarter.
  • Capital Impact Advisors sold 23,228 Teladoc Health shares in Q2 2024, an estimated $351K.
  • Capital Impact Advisors first reported a position in Teladoc Health in Q2 2020 and held it in 15 quarters.
  • Capital Impact Advisors's Teladoc Health position peaked at $6.84M in Q4 2020.
  • 405 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on Capital Impact Advisors's 13F filing for Q2 2024, filed 16 Aug 2024.